OLUBUKOLA AREMU: Open Payments
NPI 1376901199 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 25 payments from 9 companies in 2025. Trend: 2023 $353 · 2024 $394 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $179 |
| GENZYME CORPORATION | 2 | $129 |
| Janssen Biotech, Inc. | 1 | $122 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $71 |
| Arcutis Biotherapeutics, Inc. | 4 | $71 |
| Organon LLC | 7 | $63 |
| ABBVIE INC. | 2 | $46 |
| Kerecis Limited | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $20 |
Products named: OTEZLA, DUPIXENT, TREMFYA, Zoryve, VTAMA, SKYRIZI, ILUMYA, Odomzo.
Industry payments across AZ — which companies pay providers there.
